drugset / Trial / NCT00231556

A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy

NCT00231556

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the safety and effectiveness of two doses of topiramate as monotherapy in the treatment of pediatric and adult patients with newly diagnosed or recurrent epilepsy.

Timeline

Start
1999-07
Primary completion
Completion
2003-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 50 mg Oral
Subject Topiramate Small molecule 400 mg Oral